Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Queensland Health
Covington
Fuji
Cantor Fitzgerald
Express Scripts

Generated: September 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for MLN0128

  Try a free trial


See Plans and Pricing

« Back to Dashboard

US Patents for MLN0128

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
MLN0128 ➤ Sign Up Low, immune enhancing, dose mtor inhibitors and uses thereof Novartis AG (Basel, CH) ➤ Sign Up
MLN0128 ➤ Sign Up Pharmaceutical compositions and their use for treatment of cancer and autoimmune diseases ZHEJIANG DTRM BIOPHARMA CO. LTD. (Hangzhou, CN) ➤ Sign Up
MLN0128 ➤ Sign Up Combination pharmaceutical compositions and uses thereof INTELLIKINE LLC (La Jolla, CA) ➤ Sign Up
MLN0128 ➤ Sign Up Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor Novartis AG (Basel, CH) The Trustees of the University of Pennsylvania (Philadelphia, PA) ➤ Sign Up
MLN0128 ➤ Sign Up CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cell Novartis AG (Basel, CH) The Trustees of the University of Pennsylvania (Philadelphia, PA) ➤ Sign Up
MLN0128 ➤ Sign Up ULK1 inhibitors and methods using same SALK INSTITUTE FOR BIOLOGICAL STUDIES (La Jolla, CA) SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (La Jolla, CA) YALE UNIVERSITY (New Haven, CT) ➤ Sign Up
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Subscribe to access the full database, or try a Free Trial

International Patents for MLN0128

Drugname Country Document Number Estimated Expiration Related US Patent
MLN0128 Australia 2014348657 2033-11-13 ➤ Sign Up
MLN0128 Australia 2017245411 2033-11-13 ➤ Sign Up
MLN0128 Canada 2929181 2033-11-13 ➤ Sign Up
MLN0128 China 105899232 2033-11-13 ➤ Sign Up
MLN0128 Eurasian Patent Organization 201690987 2033-11-13 ➤ Sign Up
MLN0128 European Patent Office 3068435 2033-11-13 ➤ Sign Up
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Cantor Fitzgerald
Moodys
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.